These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38943398)

  • 1. Natural Health Products for Symptomatic Relief of Parkinson's Disease: Prevalence, Interest, and Awareness.
    Diadhiou S; Maas BR; Schootemeijer S; Bloem BR; de Vries NM; Calon F; Darweesh SKL; de Rus Jacquet A
    J Parkinsons Dis; 2024; 14(6):1257-1264. PubMed ID: 38943398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Parkinson's Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson's Disease in Patients and their Carers.
    Tolosa E; Ebersbach G; Ferreira JJ; Rascol O; Antonini A; Foltynie T; Gibson R; Magalhaes D; Rocha JF; Lees A
    J Parkinsons Dis; 2021; 11(3):1309-1323. PubMed ID: 34024784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use in Parkinson's disease-A nationwide online survey study.
    Erga AH; Maple-Grødem J; Alves G
    Acta Neurol Scand; 2022 Jun; 145(6):692-697. PubMed ID: 35178701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's Disease.
    Pigott JS; Bloem BR; Lorenzl S; Meissner WG; Odin P; Ferreira JJ; Dodel R; Schrag A
    J Geriatr Psychiatry Neurol; 2024 Sep; 37(5):355-367. PubMed ID: 38230692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of general practitioner's practices and knowledge about Parkinson's disease in the north of France.
    Aubignat M; Skierkowski H; Tir M
    Rev Neurol (Paris); 2024 Sep; 180(7):650-654. PubMed ID: 38556412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China.
    Li J; Chen D; Song W; Chen K; Cao B; Huang R; Yang R; Shang H
    Clin Neurol Neurosurg; 2014 Mar; 118():16-20. PubMed ID: 24529223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update.
    McFarthing K; Buff S; Rafaloff G; Pitzer K; Fiske B; Navangul A; Beissert K; Pilcicka A; Fuest R; Wyse RK; Stott SRW
    J Parkinsons Dis; 2024; 14(5):899-912. PubMed ID: 39031388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures.
    Pathak-Gandhi N; Vaidya AD
    J Ethnopharmacol; 2017 Feb; 197():46-51. PubMed ID: 27544001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach.
    So YJ; Lee JU; Yang GS; Yang G; Kim SW; Lee JH; Kim JU
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis in Parkinson's Disease: The Patients' View.
    Yenilmez F; Fründt O; Hidding U; Buhmann C
    J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discussing sexual health among Flemish patients with Parkinson's disease.
    Van Overmeire R; Vesentini L; Vanclooster S; Bilsen J
    Acta Neurol Belg; 2023 Apr; 123(2):497-505. PubMed ID: 36153464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson's disease.
    Cho BH; Choi SM; Kim JT; Kim BC
    Parkinsonism Relat Disord; 2018 May; 50():42-47. PubMed ID: 29449185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
    Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
    J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
    Angelopoulou E; Bozi M; Simitsi AM; Koros C; Antonelou R; Papagiannakis N; Maniati M; Poula D; Stamelou M; Vassilatis DK; Michalopoulos I; Geronikolou S; Scarmeas N; Stefanis L
    Parkinsonism Relat Disord; 2019 Oct; 67():105-112. PubMed ID: 31494049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication use in people with late stage Parkinson's disease and parkinsonism living at home and in institutional care in north-east England: A balance of symptoms and side-effects?
    Hand A; Gray WK; Oates LL; Woolford M; Todd A; Bale E; Jones C; Wood BH; Walker RW
    Parkinsonism Relat Disord; 2016 Nov; 32():120-123. PubMed ID: 27622968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
    Baik D; Yu YM; Jung SY; Kang HY
    BMC Geriatr; 2022 Jul; 22(1):609. PubMed ID: 35864474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important medicinal herbs in Parkinson's disease pharmacotherapy.
    Srivastav S; Fatima M; Mondal AC
    Biomed Pharmacother; 2017 Aug; 92():856-863. PubMed ID: 28599249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use in Parkinson's disease: Patient access to medical cannabis and physician perspective on product safety.
    Griffith ST; Conrow KD; Go M; McEntee ML; Daniulaityte R; Nadesan MH; Swinburne MR; Shill HA; Leung MCK
    Neurotoxicology; 2024 Jul; 103():198-205. PubMed ID: 38834158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of herbal products in the treatment of Parkinson's disease.
    Amro MS; Teoh SL; Norzana AG; Srijit D
    Clin Ter; 2018; 169(1):e23-e33. PubMed ID: 29446788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.